Related Experiment Videos
Radiofrequency ablation of multiple accessory pathways.
Pedro Iturralde1, Milton Guevara-Valdivia, Laura Rodríguez-Chávez
1Electrophysiology Department, Instituto Nacional de Cardiología Ignacio Chávez, México City, Tlalpan, DF, Mexico. pedroi@yahoo.com
Summary
Radiofrequency catheter ablation effectively treats multiple accessory pathways in Wolff-Parkinson-White Syndrome. While success rates are slightly lower than for single pathways, it offers a high success rate in a single session.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Wolff-Parkinson-White Syndrome (WPW) is characterized by accessory pathways that can be single or multiple.
- Understanding the characteristics and ablation outcomes of multiple accessory pathways is crucial for effective treatment.
Purpose of the Study:
- To review clinical and electrophysiological characteristics of radiofrequency catheter ablation in patients with multiple accessory pathways.
- To compare ablation outcomes in patients with multiple accessory pathways versus single accessory pathways.
Main Methods:
- Electrophysiological study and radiofrequency catheter ablation were performed in 1010 WPW patients.
- Multiple accessory pathways were identified in 31 patients (3.1%), with 63 pathways ablated.
- Ebstein's anomaly was noted in 9 patients with atrioventricular bypass tracts.
Main Results:
- Radiofrequency ablation successfully treated 81% of the 63 accessory pathways without complications.
- The most common pathway combination was right posteroseptal with right free wall bypass tracts.
- Recurrence was observed in 9.5% of cases after a 5-year follow-up.
Conclusions:
- Radiofrequency ablation is a viable treatment for multiple accessory pathways in WPW syndrome, achieving high success rates in a single session.
- Success rates for multiple accessory pathways (81%) were slightly lower than for single pathways (93%).
- The procedure demonstrated a high success rate and acceptable recurrence rate for complex cases.